Ensysce Biosciences (ENSC) Stock Statistics & Valuation Metrics

Ensysce Biosciences has a market cap or net worth of $8.35M. The enterprise value is $2.97.

Ensysce Biosciences has 19,456,795 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ensysce Biosciences’s return on equity (ROE) is -3.17 and return on invested capital (ROIC) is -320.89%.

The current PE Ratio of Ensysce Biosciences is ―. Ensysce Biosciences’s PEG ratio is 0.02.

In the last 12 months, Ensysce Biosciences had revenue of 0.00 and earned -10.18M in profits. Earnings per share was -3.98.

In the last 12 months, operating cash flow was -8.86M and capital expenditures -123.64K, giving a free cash flow of -8.98M billion.

Ensysce Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Ensysce Biosciences upcoming earnings date is Nov 16, 2026, After Close (Confirmed).

Ensysce Biosciences as a current ratio of 1.59, with Debt / Equity ratio of -25.18%

In the past 12 months, Ensysce Biosciences has paid 0.00 in taxes.

Ensysce Biosciences EV to EBITDA ratio is 0.16, with an EV/FCF ratio of 0.21.

Ensysce Biosciences has $676.70K in cash and marketable securities with $196.84K in debt, giving a net cash position of $479.86K billion.

Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Ensysce Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―